| Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis F Kabinger, C Stiller, J Schmitzová, C Dienemann, G Kokic, HS Hillen, ... Nature structural & molecular biology 28 (9), 740-746, 2021 | 627 | 2021 |
| Modulating androgen receptor-driven transcription in prostate cancer with selective CDK9 inhibitors A Richters, SK Doyle, DB Freeman, C Lee, BS Leifer, S Jagannathan, ... Cell chemical biology 28 (2), 134-147. e14, 2021 | 58 | 2021 |
| Mecanismo de mutagênese de SARS-CoV-2 induzida por molnupiravir F Kabinger Struct Mol Biol 28 (9), 740-746, 2021 | 2 | 2021 |
| Targeted Degradation of CDK9 Potently Disrupts the MYC Transcriptional Network MA Toure, K Motoyama, Y Xiang, J Urgiles, F Kabinger, AS Koglin, ... bioRxiv, 2024.05. 14.593352, 2024 | | 2024 |
| Modulators of myb-mediated transcription and uses thereof AN Koehler, B Leifer, F Kabinger, B Curtin, J Kruell US Patent App. 18/022,962, 2023 | | 2023 |
| Chimeric degraders of cyclin-dependent kinase 9 and uses thereof AN Koehler, A Richters, J Urgiles, F Kabinger, MA Toure US Patent App. 17/920,574, 2023 | | 2023 |
| Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis (preprint) F Kabinger, C Stiller, J Schmitzová, C Dienemann, HS Hillen, C Höbartner, ... | | 2021 |
| Targeting oncogenic transcription in prostate cancer with a novel, oral bioavailable, and ultra-selective CDK9 inhibitor A Richters, D Freeman, C Lee, F Kabinger, S Doyle, B Leifer, P Mikochik, ... Cancer Research 80 (16), 2020 | | 2020 |
| Establishing BRET assays to investigate the protein-protein interaction between transcription factor-cofactor complexes. An approach to develop small molecule inhibitors F Kabinger, FHPDT Czerny, AN Koehler | | 2020 |
